1. Vallabhajosula S, Killeen RP, Osborne JR (2010) Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. Semin Nucl Med 40:220–241
2. Hladik III WB, Norenberg JP (1996) Problems associated with the clinical use of radiopharmaceuticals: a proposed classification system and troubleshooting guide. Eur J Nucl Med 23:997–1002
3. Owunwanne A, Patel M, Sadek S, Halkar RK (1994) The biologic disposition of administered radiopharmaceuticals. In: Freeman LM (ed) Nuclear Medicine Annual, Raven Press, New York, pp 251–284
4. Hung JC, Ponto JA, Hammes RJ (1996) Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med 26:208–255
5. Javaid Khurshid S, Zubair Sadiq M (1996) Quality assurance in Nuclear Medicine — Biological quality control of radiopharmaceuticals. Pak J Pharm Sci 9:43–54